Bristol-Myers hits snag in plan to catch Merck in lung cancer - BioPharma Dive

Bristol-Myers hits snag in plan to catch Merck in lung cancer  BioPharma Dive

Bristol-Myers Squibb's chances of challenging Merck & Co. in the market for lung cancer drugs shrank on Wednesday, when the pharma announced mixed ...